FundedIQ
Biotechnology

Artan Biotechnologies: Funding, Investors & Team (Sep 2026)

Artan Biotechnologies focuses on biotechnology research and product development for life-science teams. The company develops assays, molecular biology tools, and analytical methods that support drug discovery, diagnostics, and bioprocessing. Services include contract research, custom assay design, protein expression and purification, and nucleic acid engineering, paired with consumable reagents and protocol support. Software and data workflows enable experiment tracking, quality control, and interpretation of results. Capabilities span sample preparation, sequencing support, and bioinformatics reporting, depending on project scope. Public materials emphasize translating lab methods into scalable, reproducible protocols.

www.artan.bio LinkedIn St. Petersburg, United States 1-10 employees
Bioinformatics Biotechnology Genetics B2B
Total raised
$200k
Rounds
1
Latest
Seed
Jun 2026

Artan Biotechnologies has raised $200k across 1 funding round on record, the most recent a Seed of $200k announced in Jun 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Artan Biotechnologies Company Profile and Key Stats

Total funding raised
$200k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$200k in Jun 2026
Employees
1-10
reported band
Headquarters
St. Petersburg, United States

Latest funding round on record: Jun 2026.

Artan Biotechnologies Funding Rounds

Date
Round
Amount
Seed
$200k

Artan Biotechnologies Founders and Leadership Team

Name
Role
Contact
Anthony Schwartz
Founder

No contact details are on record for this team yet.

Artan Biotechnologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
16,575
$3.1M

Artan Biotechnologies' latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Artan Biotechnologies in Biotechnology and St. Petersburg

Companies Similar to Artan Biotechnologies

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Artan Biotechnologies Funding FAQs

What does Artan Biotechnologies do?

Artan Biotechnologies focuses on biotechnology research and product development for life-science teams. The company develops assays, molecular biology tools, and analytical methods that support drug discovery, diagnostics, and bioprocessing. Services include contract research, custom assay design, protein expression and purification, and nucleic acid engineering, paired with consumable reagents and protocol support. Software and data workflows enable experiment tracking, quality control, and interpretation of results. Capabilities span sample preparation, sequencing support, and bioinformatics reporting, depending on project scope. Public materials emphasize translating lab methods into scalable, reproducible protocols.

How much funding has Artan Biotechnologies raised?

Artan Biotechnologies has raised $200k across 1 round on record. The most recent is a Seed of $200k announced in Jun 2026.

When did Artan Biotechnologies last raise funding?

Artan Biotechnologies' most recent funding round on record is a Seed of $200k, announced in Jun 2026.

Who founded Artan Biotechnologies?

FundedIQ lists Anthony Schwartz (Founder) at Artan Biotechnologies.

Where is Artan Biotechnologies headquartered?

Artan Biotechnologies is based in St. Petersburg, Florida, United States.

How many employees does Artan Biotechnologies have?

Artan Biotechnologies is in the 1-10 employee band.

How does Artan Biotechnologies' funding compare to other Biotechnology startups?

Artan Biotechnologies' latest round of $200k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Artan Biotechnologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artan Biotechnologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.